课题基金 / 基金详情

Innate Immunity in Allergic Airway Inflammation of Asthma

Innate Immunity in Allergic Airway Inflammation of Asthma
哮喘过敏性气道炎症的先天免疫
批准号:
7670470
负责人:
N. Tony Eissa
金额:
$145.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-15 至 2011-06-30

项目摘要

项目成果

N. Tony Eissa的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory syndrome that manifests through airway obstruction and airway hyper-responsiveness. Over the past 30 years evidence has accumulated that asthma has increased in prevalence and severity worldwide. Current data strongly implicate inflammation, as a major hallmark of the asthma phenotype. There are many factors that contribute to the initiation and propagation of airway inflammation of asthma including genetic and environmental factors. Recently, innate immunity has been increasingly recognized to play a significant role in airway inflammation of asthma. In this context, the overall objective of this Center proposal is to investigate the mechanisms of key factors of innate immunity to the allergic inflammation of asthma. The Center has a programmatic focus on translational research and utilizes a multidisciplinary approach. The strength of the Center lies in the unique yet complementary expertise of the founding investigators in several disciplines including human subject investigation, molecular cell biology, cytokine biology, cellular transduction, immunology, and physiology. Our program addresses three independent yet complementary factors of innate immunity that contribute to the allergic airway inflammation of asthma. These factors are nitric oxide, environmental proteases, and endogenous metalloproteinases. Project 1 will focus on elucidation of the mechanisms of overproduction of NO by iNOS in airway inflammation of asthma. It also evaluates the use of iNOS translational inhibitors in a mouse model of asthma. Project 2 will determine the earliest innate immune signaling pathway activated by allergens that conditions the lung for subsequent allergic lung disease. Further, it will determine the relationship between allergenic proteinases in home environments and the development of childhood asthma. Project 3 will define the role of key matrix proteinases and proteoglycans in coordinating the crosstalk between immune and non-immune cells in the lung and in orchestrating the progression of allergic inflammation and clearance of inflammatory cells from lung. All three projects study asthma patients as well as mouse models of asthma. Three cores support the Center. The Administrative Core (Core A) has the overall responsibility of managing all scientific and administrative aspects of the Center. Core B (Animal Core) assists investigators in all studies related to the development and testing of a mouse model of asthma. Core C handles primary cell culture, tissue processing and imaging needs of Center investigators. The results of the studies, in this highly interactive Center, will increase our understanding of the pathophysiology and potential therapy for asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
  • 批准号:
    8768835
  • 项目类别:
  • 资助金额:
    $153.78万
  • 财政年份:
    2013
  • 负责人:
    N. Tony Eissa
  • 依托单位:
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
  • 批准号:
    8599141
  • 项目类别:
  • 资助金额:
    $127.46万
  • 财政年份:
    2013
  • 负责人:
    N. Tony Eissa
  • 依托单位:
CYSTIC FIBROSIS MUTANT
  • 批准号:
    8361139
  • 项目类别:
  • 资助金额:
    $1.23万
  • 财政年份:
    2011
  • 负责人:
    N. Tony Eissa
  • 依托单位:
Cellular Regulation of Nitric Oxide in Airway Inflammation
  • 批准号:
    7824705
  • 项目类别:
  • 资助金额:
    $1.78万
  • 财政年份:
    2009
  • 负责人:
    N. Tony Eissa
  • 依托单位:
海外基金